Skip to main content
. 2022 May 12;28(16):3433–3442. doi: 10.1158/1078-0432.CCR-22-0305

Figure 1.

Figure 1. Kaplan–Meier curves of OS in all patients in the intent-to-treat population. FUL = fulvestrant; HR = hazard ratio; OS = overall survival; PAL = palbociclib; PBO = placebo.

Kaplan–Meier curves of OS in all patients in the intent-to-treat population. FUL, fulvestrant; HR, hazard ratio; OS, overall survival; PAL, palbociclib; PBO, placebo.